FTC asks 11th Circuit to reconsider Schering ruling
from Reuters:
U.S. antitrust authorities on Friday, April 22, asked a federal appeals court to reconsider a recent ruling that reversed a finding that Schering-Plow Corp. illegally kept cheaper versions of its blood pressure drug K-Dur off the market.
The staff of the U.S. Federal Trade Commission filed a petition with the U.S. Court of Appeals for the 11th Circuit in Atlanta requesting that the full court review the case, the agency said.
A three-judge panel on March 8 rejected a 2003 FTC ruling that concluded Schering-Plough's patent settlements with two other companies amounted to pay-offs not to compete.
U.S. antitrust authorities on Friday, April 22, asked a federal appeals court to reconsider a recent ruling that reversed a finding that Schering-Plow Corp. illegally kept cheaper versions of its blood pressure drug K-Dur off the market.
The staff of the U.S. Federal Trade Commission filed a petition with the U.S. Court of Appeals for the 11th Circuit in Atlanta requesting that the full court review the case, the agency said.
A three-judge panel on March 8 rejected a 2003 FTC ruling that concluded Schering-Plough's patent settlements with two other companies amounted to pay-offs not to compete.
posted by Lawrence B. Ebert at 7:29 PM
0 Comments:
Post a Comment
<< Home